Synergistic killing in pancreatic cancer cell lines of the combination of a MEK inhibitor and DNA methylation inhibitor.

被引：0
|
作者：
Jeffries, Matlock Arizona
Kurkjian, Carla
机构：
[1] Univ Oklahoma Hlth Sci Ctr, Oklahoma City, OK USA
[2] Stephenson Canc Ctr SCRI, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15025
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
    Simiczyjew, Aleksandra
    Dratkiewicz, Ewelina
    Van Troys, Marleen
    Ampe, Christophe
    Styczen, Ilona
    Nowak, Dorota
    CANCERS, 2018, 10 (09)
  • [42] MEK inhibitor effective against proliferation in breast cancer cell
    Zhou, Yan
    Hu, Hai-yan
    Meng, Wei
    Jiang, Ling
    Zhang, Xing
    Sha, Jing-jing
    Lu, Zhigang
    Yao, Yang
    TUMOR BIOLOGY, 2014, 35 (09) : 9269 - 9279
  • [43] Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines
    Waissi, Waisse
    Ame, Jean-Christophe
    Mura, Carole
    Noel, Georges
    Burckel, Helene
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (13)
  • [44] The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244
    Wang, Ting
    Wei, Jue
    Wang, Na
    Ma, Jia-Li
    Hui, Ping-Ping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 456 (03) : 821 - 826
  • [45] BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines
    Borst, Andreas
    Haferkamp, Sebastian
    Grimm, Johannes
    Roesch, Manuel
    Zhu, Guannan
    Guo, Sen
    Li, Chunying
    Gao, Tianwen
    Meierjohann, Svenja
    Schrama, David
    Houben, Roland
    CANCER LETTERS, 2017, 404 : 70 - 78
  • [46] Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor
    Amada, Kohei
    Hijiya, Naoki
    Ikarimoto, Sawa
    Yanagihara, Kazuyoshi
    Hanada, Toshikatsu
    Hidano, Shinya
    Kurogi, Shusaku
    Tsukamoto, Yoshiyuki
    Nakada, Chisato
    Kinoshita, Keisuke
    Hirashita, Yuka
    Uchida, Tomohisa
    Shin, Toshitaka
    Yada, Kazuhiro
    Hirashita, Teijiro
    Kobayashi, Takashi
    Murakami, Kazunari
    Inomata, Masafumi
    Shirao, Kuniaki
    Aoki, Masahiro
    Takekawa, Mutsuhiro
    Moriyama, Masatsugu
    CANCER SCIENCE, 2023, 114 (05) : 2189 - 2202
  • [47] MTOR inhibitor-based combination therapies for pancreatic cancer
    Hassan, Zonera
    Schneeweis, Christian
    Wirth, Matthias
    Veltkamp, Christian
    Dantes, Zahra
    Feuerecker, Benedikt
    Ceyhan, Gueralp O.
    Knauer, Shirley K.
    Weichert, Wilko
    Schmid, Roland M.
    Stauber, Roland
    Arlt, Alexander
    Kraemer, Oliver H.
    Rad, Roland
    Reichert, Maximilian
    Saur, Dieter
    Schneider, Guenter
    BRITISH JOURNAL OF CANCER, 2018, 118 (03) : 366 - 377
  • [48] MTOR inhibitor-based combination therapies for pancreatic cancer
    Zonera Hassan
    Christian Schneeweis
    Matthias Wirth
    Christian Veltkamp
    Zahra Dantes
    Benedikt Feuerecker
    Güralp O Ceyhan
    Shirley K Knauer
    Wilko Weichert
    Roland M Schmid
    Roland Stauber
    Alexander Arlt
    Oliver H Krämer
    Roland Rad
    Maximilian Reichert
    Dieter Saur
    Günter Schneider
    British Journal of Cancer, 2018, 118 : 366 - 377
  • [49] Impact of hypomethylating agents on hTERT expression and synergistic effect in combination with imetelstat, a telomerase inhibitor, in AML cell lines
    Rusbuldt, Joshua
    Bussolari, Jacqueline
    Rizo, Aleksandra
    Huang, Fei
    CANCER RESEARCH, 2016, 76
  • [50] Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor
    Witters, Lois M.
    Witkoski, Amy
    Planas-Silva, Maricarmen D.
    Berger, Mark
    Viallet, Jean
    Lipton, Allan
    ONCOLOGY REPORTS, 2007, 17 (02) : 465 - 469
12345